- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: phosphoinositide-3 kinase (PI3K)
Total 26151 results
-
Kazia Therapeutics LimitedQuotient SciencesCompleted
-
Children's Hospital of Fudan UniversityRecruitingActivated PI3K-delta Syndrome | Immunodeficiency PrimaryChina
-
Rhizen Pharmaceuticals SACompletedLymphoma, B-Cell | T-Cell LymphomaFrance, Italy
-
Shanghai Jiatan Pharmatech Co., LtdCompleted
-
Rhizen Pharmaceuticals SAWithdrawnPeripheral T Cell LymphomaUnited States
-
AstraZenecaParexelCompleted
-
Rhizen Pharmaceuticals SACompletedLymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.Completed
-
Rhizen Pharmaceuticals SACompletedLeukemia, Lymphocytic, Chronic, B-CellGeorgia, Bulgaria, Poland
-
Rhizen Pharmaceuticals SACompleted
-
Rhizen Pharmaceuticals SACompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGeorgia
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
PIQUR Therapeutics AGCharite University, Berlin, Germany; University Hospital, Basel, Switzerland; University Hospital Freiburg and other collaboratorsCompletedLymphoma | Non-Hodgkin LymphomaGermany
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
PIQUR Therapeutics AGRoyal Marsden NHS Foundation Trust; University College London Hospitals; Weill... and other collaboratorsCompletedLymphoma, MalignantUnited States, United Kingdom, Serbia, Bosnia and Herzegovina, France, Israel
-
GlaxoSmithKlineTerminatedSolid TumoursUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
University of California, San FranciscoNovartis Pharmaceuticals; Pediatric Brain Tumor Foundation; The Lilabean Foundation...RecruitingHigh Grade Glioma | Low-grade Glioma | Recurrent World Health Organization (WHO) Grade II GliomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
GlaxoSmithKlineCompleted
-
SecuraBioCompletedA Phase 3 Study of Duvelisib Versus Ofatumumab in Patients With Relapsed or Refractory CLL/SLL (DUO)Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, Germany, United Kingdom, Australia
-
SecuraBioCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaBelgium, France, Italy, Spain, United States, Austria, New Zealand, Hungary, United Kingdom, Australia, Germany
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownFollicular Lymphoma(FL) | Marginal Zone Lymphoma(MZL)China
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | B-Cell Non-Hodgkin Lymphomas(NHL)China
-
Celcuity, Inc.Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
University of ArizonaNational Cancer Institute (NCI)TerminatedHPV Positive Oropharyngeal Squamous Cell Carcinoma | Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 | Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 | CDKN2A-p16 Positive | Stage I Oropharyngeal Squamous Cell Carcinoma AJCC V7 | Stage II Oropharyngeal Squamous Cell Carcinoma...United States
-
Novartis PharmaceuticalsCompletedAdvanced or Metastatic Breast CancerSpain, United States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompletedPI3K Pathway Activated TumorsUnited States
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
BayerCompleted
-
Gilead SciencesTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Incyte CorporationCompletedAutoimmune Hemolytic AnemiaUnited States, France, Italy, Austria
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Rhizen Pharmaceuticals SACompletedHematological MalignanciesUnited States, Georgia, Poland
-
Dana-Farber Cancer InstituteGilead SciencesTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Convalife (Shanghai) Co., Ltd.Not yet recruiting
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdRecruitingTriple Negative Breast Cancer (TNBC)India
-
Incyte CorporationTerminatedMPN (Myeloproliferative Neoplasms)United States
-
GlaxoSmithKlineCompletedActivated PI3K-delta SyndromeUnited Kingdom
-
Pamela MunsterNovartisWithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Solid Tumors, Adult | HPV-Related Squamous Cell Carcinoma | Human Papillomavirus-Related Carcinoma | PIK3CA Mutation-Related Tumors | PIK3CA Mutation | Human Papillomavirus-Related Squamous Cell CarcinomaUnited States
-
Incyte CorporationActive, not recruitingLymphomaUnited States, Spain, France, United Kingdom, Czechia, Israel, Belgium, Italy, Germany, Poland, Denmark
-
Shanghai Changzheng HospitalCompleted
-
Institute of Hematology & Blood Diseases Hospital...YL-PharmaRecruitingRelapsed/Refractory Large Granular T Lymphocytic LeukemiaChina
-
Incyte CorporationCompletedLymphomaSpain, Hungary, United States, Denmark, Italy, Czechia
-
Incyte CorporationActive, not recruitingLymphomaUnited States, Spain, Italy, Israel, Poland, United Kingdom, Canada, Czechia, Germany, Denmark, Australia, Hungary, Sweden